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A B S T R A C T
The aim of this study was to establish effect of 14 day consumption of commercially available yoghurt containing
Lactobacillus rhamnosus ATCC53103 – LGG (Bioaktiv LGG, Dukat, Croatia) on Streptococcus mutans and Lactobacil-
lus spp. salivary counts in children. Twenty five patients, 6–10yr old participated in the study. At the inclusion in the
study caries risk for every patient was evaluated. The saliva samples were tested with chair side kits for saliva buffer ca-
pacity (CRT buffer, Vivadent, Schaan, Liechtenstein), S. Mutans and Lactobacillus counts (CRT bacteria test, Vivadent,
Schaan, Liechtenstein). Seven, 14 and 30d after yoghurt consumption saliva samples were tested again with CRT buffer
and CRT bacteria tests. Obtained data were analyzed using c2 and Kruskal-Wallis tests. Results showed significant in-
crease in saliva buffer capacity 30d after yoghurt consumption. S. Mutans salivary counts were significantly decreased
after 30d. Significant differences in Lactobacillus counts were not observed. It could be concluded that daily consump-
tion of yoghurt containing LGG have an inhibitory effect on oral pathogenic bacteria and may be beneficial in caries pre-
vention.
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Introduction
Use of probiotic products in medicine has become very
effective in the prevention and treatment of many dis-
eases, mostly intestinal and urogenital1,2. In general
terms the word pro-biotic means for life and the defini-
tion issued by the International Scientific Association for
Probiotics and Prebiotic is live micro organisms adminis-
tered in adequate amounts that confer a health benefit
on the host1. That micro organisms are usually part of
the normal flora and this approach in therapy and pre-
vention was first applied in the treatment of intestinal
diseases. The general principle of bacteriotherapy or re-
placement therapy is to change the local micro-ecology,
since the aim of treatment is to introduce and stimulate
harmless (no pathogen) bacterial species3–5.
The specific actions of the probiotic micro organisms
involved are competition with pathogenic bacteria, influ-
ence on mucosa permeability and restitution of gut
micro-ecology and influence on inflammation process.
Generally speaking, the oral cavity is also part of the gas-
trointestinal system. The same mechanisms of action of
probiotic bacteria can be adopted for caries prevention.
In the oral cavity direct and indirect actions of probiotics
can be observed: they directly influence binding of bacte-
ria to proteins and other bacteria, influence bacterial me-
tabolism and produce substances that inhibit cariogenic
bacteria. Indirect actions are the same as in other parts
of the intestinal system6,7.
Most microorganisms that are considered to be pro-
biotic are: Lactobacillus spp., and Bifidobacterium spp.
There are many others and genetical engineering is
strongly involved in the fabrication of new species. Lacto-
bacillus rhamnosus is today one of the most popular bac-
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terial species that is used as probiotic. It was isolated in
1985 by Gorbach and Goldin from the human intestine8.
Laboratory research showed that it has inhibitory action
on Streptococcus mutans and Candida albicans, it also
has good adhesion to mucosal and dental tissues and it
does not metabolise sucrose9.
The aim of the present study was to test the effect of
14 day consumption of commercially available yoghurt
containing L. Rhamnosus ATCC53103 – LGG on S. Mu-
tans and Lactobacillus spp. salivary counts.
Materials and Methods
The sample size comprised 25 patients 6–10 yr old
who voluntarily participated in the study. The study was
explained to the parents and their children who accepted
to participate in this study. They also received written ex-
planation of the study, after which the parents signed the
informed consent. The study protocol was in accordance
with the Helsinki Declaration of Human Rights and was
approved by the Ethical Committee at the School of Dental
Medicine, University of Zagreb. All participants included
in the study were healthy and had not used antibiotics or
probiotics within the 2-weeks during the washout period
prior to the study. Prior to commencing the study caries
risk was assessed for each patient. Each patient con-
sumed 200g of yoghurt daily, containing LGG bacteria
(Bioaktiv LGG, Dukat, Croatia) during a continuous pe-
riod of 14 days. After the washout period and before
starting yoghurt consumption S. Mutans, Lactobacillus
counts and saliva buffer capacity were established using
CRT bacteria and CRT buffer tests (Vivadent, Schaan,
Liechtenstein).
S. Mutans and Lactobacillus counts were also acquired
14 and 30 days after the study started. The obtained data
were analyzed using c2 and Kruskal-Wallis tests.
Results
The results obtained in this study are shown in Tables
2–5. Statistically significant reduction of S. Mutans co-
unt was noted after 30 days of daily yoghurt consump-
tion. At the start of the study ten patients displayed low
caries risk, four patients had medium caries risk while
eleven patients showed high caries risk (Table 1).
Results show that thirty days after yoghurt consump-
tion percentage of the patients with high S. Mutans
count dropped significantly from 80% to just 52% (Table
2). In the high caries activity group, high S. Mutans
count dropped from 91% to 40%, which was highly signif-
icant as well (Table 3).
The level of Lactobacillus count remained almost the
same as at the start of the study. There was no significant
difference after 14 days consumption of LGG yoghurt
(Table 4). On the contrary, saliva buffer capacity differed
significantly and was increased. Thirty days from the
start of the study 86% of patients had high buffer capac-
ity compared to 64% at the start. From 36% of patients
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TABLE 1





Male 5 3 7 15
Female 5 1 4 10
Total 10 (40%) 4 (16%) 11 (44%) 25
TABLE 2





Base 14 d 30 d
÷2 (p)
N % N % N %
>105 20 80 18 79 11 52
0.047<105 5 20 5 21 10 48
Total 25 100 23 100 21 100
TABLE 3
S. MUTANS COUNTS IN HIGH CARIES RISK GROUP
Caries risk
(high)
S. Mutans Base S. Mutans 30 d
÷2 (p)














LACTOBACILLUS SPP. COUNTS AFTER 14D DAILY




Base 14 d 30 d
c2 (p)
N % N % N %
>105 8 32 12 52 7 33
0.58<105 17 68 11 48 14 67
Total 25 100 23 100 21 100
TABLE 5




Saliva buffer capacity Kruskal
Wallis
(p)
Base 14 d 30 d
N % N % N %
Low 0 0 1 4 0 0
0.035
Medium 9 36 7 29 3 14
High 16 64 16 67 18 86
Total 25 100 24 100 21 100
with medium buffer capacity before yoghurt administra-
tion, medium buffer capacity dropped to only 14% of pa-
tients (Table 5).
Discussion
Products with probiotic effect comprise milk, cheese,
yoghurt, juice, ice cream, lozenges etc.2. In order to be ef-
fective probiotic bacteria should adhere to the tooth sur-
face, become part of the oral biofilm and compete with
other existing and cariogenic bacterial species, reducing
the level of their colonisation. Comelli et al. showed such
an effect of Lactoccocus lactis on colonization of S. So-
brinus. They also noted that molecule of caseinglyco-
macropeptide (CGMP), component of milk, can have an
inhibitory effect on attachment of S. Mutans and S.
Sobrinus on hydroxyapatite10. It is suggested that the ve-
hicle for administration of probiotics should be of milk
origin due to contained casein phosphopeptides (CPPs)
that have inhibitory effect on demineralization and pro-
mote the remineralization of dental enamel11,12. Gug-
genheim et al describe inhibitory effect of powdered milk
micellar casein on colonization of S. Sobrinus, but the
authors state that soluble form of caseinate does not re-
tain such effect13. Also Reynolds and Johnson, and Rey-
nolds and Black reports that caseins are caries preven-
tive without affecting S. Mutans14,15. Bussher et al.16 and
Caglar et al.17 used yoghurt as the vehiculum for lacto-
bacilli and Bifidobacterium bifidum. In their study Caru-
ana et al. showed that casein phosphopeptide-amorphous
calcium phosphate (CPP–ACP) complex can reduce the
fall of plaque pH following carbohydrate challenge18.
Haukioja et al. noted that Lactobacillus spp. and Bi-
fidobacteria can survive in saliva for at least 24 hours.
They also showed that Lactobacillus rhamnosus GG ad-
heres well to hydroxyapatite, although there is a differ-
ence in the quality of adhesion between different individu-
als. It seems that saliva components influence adhesion19.
Results obtained in this study confirm the results of
Nase et al. who found a significant decrease in S. Mutans
count after LGG milk consumption20. This finding was
observed in a population of 3–4 year-old children. Also,
Ahola et al. noted a 20% decrease of S. Mutans count af-
ter consumption of cheese with addition of LGG21. De-
crease in S. Mutans count was observed in the post-treat-
ment period, while during the treatment the values were
insignificant. The results of this study are in agreement
with Ahola’s study, a significant decrease in S. Mutans
count was observed 30 days after yoghurt consumption.
Wei et al. demonstrated a reduction in adherence of S.
Mutans to enamel hydroxyapatite by 40% when LGG was
added to milk without antibodies. However, reduction in
adherence of S. Mutans increases to 70% in the presence
of antibodies in LGG fermented milk22. According to
Meurman et al. manifestation of the preventive effect of
Lactobacillus rhamnosus GG is not only in competition
for adherence sites with S. Mutans, but also in metabo-
lism, because of the fact that LGG does not ferment
sucrose23. Sucrose serves not only as a metabolic sub-
strate for cariogenic bacteria, but also has a cariogenic
effect per se. A review by Paes Leme et al. showed that
the role of sucrose is not yet completely elucidated24. Su-
crose is important as a substrate for extracellular (EPS)
and intracellular polysaccharides (IPS) formation. EPS
promote bacterial adherence to the tooth surface and
contribute to the structural integrity of dental biofilm.
Also, sucrose reduces concentration of Ca, inorganic phos-
phorus (Pi) and F in the dental plaque. Ions of Ca, (Pi)
and F are important in maintaining equilibrium between
the tooth and the oral environment in view of that fact
that reduced ion availability may increase the cariogenic
potential of the biofilm24.
Significant differences in Lactobacilli count between
caries-free and caries-active individuals were observed in
some previous studies. Simark-Mattsson et al. in their in
vitro study showed that only 31% of the study subjects
with low caries risk harboured S. Mutans compared to
71% and 89% in groups with moderate and high caries
activity respectively. Lactobacilli in a group without car-
ies activity repressed the growth of their autologous S.
Mutans. Species with most effective interference capac-
ity were L. Paracasei, L. Plantarum and L. Rhamnosus25.
These results are in accordance with a review by van
Palenstein Helderman et al. showing that S. Mutans is
ubiquitous in children aged 7 years and older in Africa,
Europe and North America, regardless of diet26.
Besides LGG, it was noted that some other probiotic
bacterial strains can be effective in decreasing S. Mutans
counts. Such properties show genetically engineered S.
Mutans JH 1000, S. Equi subspecies zooepidemicus, S.
Salivarius TOVE-R, E. Faecalis, Bifidobacterium DN-
-173, Lactobacillus spp27,28.
Caglar et al. showed significant reduction in S. Mutans
count in study subjects (aged 20 years) sucking a medical
device containing a probiotic lozenge with L. Reuteri29.
Concerning saliva buffer capacity, it was observed
that this value did not drop from high to low or medium
in none of the cases. On the contrary, in all patients, the
buffer capacity increased from low and medium to high.
Thus, most of the patients with medium buffer capacity
increased their buffer capacity, although all the patients
with high buffer capacity retained their high values. This
observation confirms the assumption that casein phos-
phopeptide–amorphous calcium phosphate (CPP–ACP)
complex can influence pH or probiotics application can
have preventive effects per se, and can lead to the reduc-
tion of bacterial acid production. This is matter of fur-
ther investigation.
Conclusions
The results of this study show that daily consumption
of LGG yoghurt can have an inhibitory effect on oral
pathogenic microflora. Yoghurt also significantly increas-
es saliva buffer capacity 30 days after consumption. The
obtained results allow the conclusion that daily con-
sumption of LGG yoghurt can be recommended as a ben-
eficial procedure in caries prevention.
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U^INAK LGG JOGURTA NA SALIVARNU RAZINU S. MUTANS-a I LAKTOBACILLUS SPP. U DJECE
S A @ E T A K
Svrha ovog istra`ivanja bila je ustanoviti u~inak 14-dnevnog uzimanja jogurta s dodatkom probiotika Lactobacillus
rhamnosus ATCC53103- LGG (Bioaktiv LGG, Dukat, Hrvatska) na salivarnu razinu Streptococcus mutans-a i Lacto-
bacillus spp. u djece. Istra`ivanje je provedeno na 25 djece, 6–10 godina starosti. Prilikom uklju~ivanja u istra`ivanje
svakom pacijentu je ustanovljen karijes rizik. Testiran je tako|er puferski kapacitet sline (CRT buffer, Vivadent, Scha-
an, Liechtenstein) te je ustanovljena razina S. Mutansa i Lactobacila (CRT bacteria test, Vivadent, Schaan, Liechten-
stein). Uzorci sline su testirani ponovo 7, 14 i 30 dana nakon uzimanja jogurta. Dobiveni podaci su analizirani nepa-
rametrijskim statisti~kim testovima c2 i Kruskal-Wallis. Rezultati su pokazali zna~ajan porast puferskog kapaciteta
sline 30 dana nakon uzimanja probioti~kog jogurta. Razina S. Mutansa u slini 30 dana nakon uzimanja jogurta bila je
zna~ajno sni`ena. Statisti~ki zna~ajna razlika u razini Laktobacila nije ustanovljena. Mogu}e je zaklju~iti da svako-
dnevno uzimanje jogurta s dodatkom LGG ima inhibitorno djelovanje na oralne patolo{ke bakterije i mo`e biti u~in-
kovito u prevenciji karijesa.
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